CSIMarket Company Name, Ticker, Industry, else..
 
Bright Minds Biosciences Inc   (NASDAQ: DRUG)
 

Bright Minds Biosciences Inc's Suppliers Performance

DRUG's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
DRUG Costs vs Sales of Suppliers Growth

• More on DRUG Suppliers






Bright Minds Biosciences Inc's Comment on Supply Chain


The Company conducts certain clinical development activities in Australia through arrangements with local contract research organizations (CROs), clinical sites, and service providers. It relies on the availability and performance of these Australian CROs, clinical sites, and investigators for clinical drug trials. To mitigate risks associated with foreign operations, the Company engages reputable CROs and trial sites and operates within established jurisdictions such as Australia. The Company considers its Australian clinical activities to be adequately resourced and compliant with regulatory and ethical requirements. The Company does not anticipate significant volatility in raw materials or finished goods pricing and is not substantially dependent on any contracts.

Bright Minds Biosciences Inc's Comment on Supply Chain


The Company conducts certain clinical development activities in Australia through arrangements with local contract research organizations (CROs), clinical sites, and service providers. It relies on the availability and performance of these Australian CROs, clinical sites, and investigators for clinical drug trials. To mitigate risks associated with foreign operations, the Company engages reputable CROs and trial sites and operates within established jurisdictions such as Australia. The Company considers its Australian clinical activities to be adequately resourced and compliant with regulatory and ethical requirements. The Company does not anticipate significant volatility in raw materials or finished goods pricing and is not substantially dependent on any contracts.







DRUG's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bright Minds Biosciences Inc 419.42 0.00 -9.37 57
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bright Minds Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bright Minds Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.